Xing L - Search Results

1

Risk factors for polymyxin B-associated acute kidney injury.

Chang K, Wang H, Zhao J, Yang X, Wu B, Sun W, Huang M, Cheng Z, Chen H, Song Y, Chen P, Chen X, Gan X, Ma W, Xing L, Wang Y, Cao B. Chang K, et al. Among authors: xing l. Int J Infect Dis. 2022 Apr;117:37-44. doi: 10.1016/j.ijid.2022.01.055. Epub 2022 Jan 30. Int J Infect Dis. 2022. PMID: 35108608 Free article.

2

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii.

Chang K, Wang H, Zhao J, Yang X, Wu B, Sun W, Huang M, Cheng Z, Chen H, Song Y, Chen P, Chen X, Gan X, Ma W, Xing L, Wang Y, Gu X, Zou X, Cao B. Chang K, et al. Among authors: xing l. Front Med (Lausanne). 2022 Jun 10;9:772372. doi: 10.3389/fmed.2022.772372. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755062 Free PMC article.

3

Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial.

Liu S, Wu Y, Qi S, Shao H, Feng M, Xing L, Liu H, Gao Y, Zhu Z, Zhang S, Du Y, Lu Y, Yang J, Chen P, Sun T. Liu S, et al. Among authors: xing l. Crit Care. 2023 Jun 13;27(1):232. doi: 10.1186/s13054-023-04522-6. Crit Care. 2023. PMID: 37312218 Free PMC article. Clinical Trial.

4

The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021-2022 flu season in China.

Chang D, Lin M, Song N, Zhu Z, Gao J, Li S, Liu H, Liu D, Zhang Y, Sun W, Zhou X, Yang B, Li Y, Wang L, Xiao Z, Li K, Xing L, Xie L, Sharma L. Chang D, et al. Among authors: xing l. Virol J. 2023 Aug 24;20(1):189. doi: 10.1186/s12985-023-02115-x. Virol J. 2023. PMID: 37620959 Free PMC article.

5

Fibroblast Growth Factor 21 dependent TLR4/MYD88/NF-κB signaling activation is involved in lipopolysaccharide-induced acute lung injury.

Gao J, Liu Q, Li J, Hu C, Zhao W, Ma W, Yao M, Xing L. Gao J, et al. Among authors: xing l. Int Immunopharmacol. 2020 Mar;80:106219. doi: 10.1016/j.intimp.2020.106219. Epub 2020 Jan 25. Int Immunopharmacol. 2020. PMID: 31991373

6

[Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to influenza infection].

Duan J, Yang Y, Hou S, Xing X, Sun M, Liu Y, Xing L. Duan J, et al. Among authors: xing x, xing l. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1304-1309. doi: 10.3760/cma.j.cn121430-20200827-00598. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463487 Chinese.

7

Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing.

Duan J, Gao J, Liu Q, Sun M, Liu Y, Tan Y, Xing L. Duan J, et al. Among authors: xing l. Front Med (Lausanne). 2022 Mar 3;9:812698. doi: 10.3389/fmed.2022.812698. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35308503 Free PMC article.

8

Tanreqing Injection Attenuates Macrophage Activation and the Inflammatory Response via the lncRNA-SNHG1/HMGB1 Axis in Lipopolysaccharide-Induced Acute Lung Injury.

Hu C, Li J, Tan Y, Liu Y, Bai C, Gao J, Zhao S, Yao M, Lu X, Qiu L, Xing L. Hu C, et al. Among authors: xing l. Front Immunol. 2022 Apr 25;13:820718. doi: 10.3389/fimmu.2022.820718. eCollection 2022. Front Immunol. 2022. PMID: 35547731 Free PMC article.

9

Efficacy of low-dose corticosteroids in patients with acute respiratory distress syndrome: a prospective observational study.

Zhang R, Huang X, Lu H, Fan G, Cai Y, Tian Y, Xia J, Deng W, Wang D, Li J, Wang S, Xing L, Liu S, Sun T, Wu D, Zhan Q, Wang C; CHARDSnet group*; CHARDSnet group. Zhang R, et al. Among authors: xing l. J Thorac Dis. 2022 Jul;14(7):2511-2521. doi: 10.21037/jtd-21-890. J Thorac Dis. 2022. PMID: 35928619 Free PMC article.

10

Negative results of bronchoalveolar lavage fluid metagenomic next-generation sequencing in critically ill patients.

Ma W, Zhao Y, Lu X, Zhang L, Ma X, Gao J, Hou J, Liu Q, Zhao S, Yao M, Xing L. Ma W, et al. Among authors: xing l. Front Cell Infect Microbiol. 2022 Oct 25;12:962283. doi: 10.3389/fcimb.2022.962283. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36389134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,675 results

Search Page